Hangtian Yue

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 1

Top Topics

Inflammatory Response

Metastatic Breast Cancer

Diffusion Weighted

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Hangtian Yue, Hui Xu, Lanping Ma, Xiyuan Li, Biyu Yang, Xiyuan Wang, Qingzhong Zeng, Han Li, Deqiang Zhang, Meiyu Geng, Tao Meng, Zuoquan Xie
A DXd/TLR7-agonist dual-conjugate anti-HER2 ADC exerts robust anti-tumor activity through tumor cell killing and immune activation. Molecular cancer therapeutics (2024)